位置:成果数据库 > 期刊 > 期刊详情页
射线联合嵌合启动子介导的自杀基因对肿瘤细胞的靶向杀伤作用
  • ISSN号:0253-3766
  • 期刊名称:《中华肿瘤杂志》
  • 时间:0
  • 分类:R979.1[医药卫生—药品;医药卫生—药学]
  • 作者机构:[1]武汉大学中南医院放化疗科湖北省肿瘤生物学行为重点实验室,430071
  • 相关基金:国家自然科学基金(30672438);湖北省自然科学基金创新项目(2006ABC009);武汉市攻关项目(200960323129)
中文摘要:

目的探讨放射线联合新型嵌合启动子介导辣根过氧化物酶/吲哚乙酸(HRP/IAA)自杀基因系统特异高效的抗肿瘤作用。方法构建含有4个串联放射反应元件CArG、含或不含巨细胞病毒(CMV)启动子的人端粒酶逆转录酶嵌合启动子,筛选肿瘤特异性及放射诱导性强的嵌合启动子,下游连接自杀基因辣根过氧化物酶(HRP),检测放射线联合基因治疗对肿瘤细胞HeLa、A549和MHCC97增殖及凋亡的影响。结果人胚肺成纤维细胞MRC-5中C4-hTC嵌合启动子的活性(0.1±0.0)明显低于肿瘤细胞株HeLa、A549和MHCC97(0.6±0.0、1.1±0.1和1.0±0.1,P〈0.01),经过6Gy射线诱导后,这种差异更加显著(活性分别为0.2±0.1、1.7±0.2、2.3±0.2和2.3±0.1,P〈0.01)。在肿瘤细胞株HeLa、A549和MHCC97中,嵌合启动子C4-hTC-HRP携带的自杀基因系统SER值分别为2.64、2.75和2.82,显著高于单纯hTERT启动子。在肿瘤细胞中,除阴性对照质粒pGL3-contr01.Luc外,自杀基因与放射治疗相联合对肿瘤细胞的生长抑制明显高于单一治疗方法,而联合组中pC4-hTC.HRP/IAA系统与放射联合的生长抑制作用最显著,对HeLa、A549和MHCC97细胞的生长抑制率分别为67.3%、69.0%和64.6%。在肿瘤细胞中,除阴性对照质粒pGL3-control-Luc外,联合组诱导的早期凋亡率明显高于单一治疗方法组,其中pC4-hTC-HRP/IAA系统与放射联合诱导的凋亡率最高,HeLa、A549和MHCC97细胞凋亡率分别为39.6%、33.0%和33.2%。结论新型嵌合启动子C4-hTC具有良好的肿瘤特异性及放射诱导性,放射线联合基因治疗对肿瘤细胞具有特异高效的杀伤作用,在肿瘤的基因放疗中具有较强的应用潜力。

英文摘要:

Objective To explore the synergistic anti-tumor effect of radiotherapy and horseradish peroxidase/prodrug indole-3-acetic acid (HRP/IAA) gene therapy system using chimeric hTERT promoter responsive to ionizing radiation. Methods The synthetic hTERT promoters containing four tandem-repeat copies of radio-inducible CArG elements, and the chimeric promoter containing cytomegalovirus (CMV) early promoter were both constructed. The activities of the chimeric promoters in cancer cell lines ( HeLa, A549, and MHCC97 ) and normal cell line ( MRC-5 ) were detected using luciferase reporter gene expression analysis after a^60Co γ-irradiation treatment at a series of doses( a single dose of 0 to 10 Gy). The anti-tumor effect of combining irradiation with HRP/IAA gene-directed enzyme prodrug therapy system controlled by the chimeric promoter was tested by colony formation assay, cell counting and apoptosis analysis. Results The chimeric promoters were ineffective in normal human cells, even after irradiation, but the expression of luciferase gene in tumor cells was significantly higher. The activity of the chimeric promoter in MRC-5 cells was 22.3% , 12.9% and 13.6% of that in HeLa, A549 and MHCC97 cells, respectively. After irradiation, the ratios were 11.7%, 8.7% and 8.8%, respectively. Furthermore, the chimeric promoters could successfully induce the expression of luciferase gene following different doses of radiation, with maximalinducible activity seen after 6 Gy irradiation. The chimeric promoter containing four tandem-repeat copies of radio-inducible CArG elements and CMV early promoter showed the highest activity with 6 Gy irradiation. The relative luciferase activities in HeLa, A549 and MHCC97 ceils were 1.7 ± 0.2, 2.3 ±0.2 and 2.3 ± 0.1, respectively. The chimeric promoter mediated suicide gene therapy system could increase radio- sensitivity in different cancer cells. Compared with the control system, it plus irradiation showed stronger cell proliferation inhibition, 67.3% vs. 26.1% in HeLa,

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华肿瘤杂志》
  • 北大核心期刊(2011版)
  • 主管单位:中国科协
  • 主办单位:中华医学会
  • 主编:
  • 地址:北京市朝阳区潘家园17号
  • 邮编:100021
  • 邮箱:zhoonghuazhongliu@163@com
  • 电话:010-67788231
  • 国际标准刊号:ISSN:0253-3766
  • 国内统一刊号:ISSN:11-2152/R
  • 邮发代号:2-47
  • 获奖情况:
  • 科协优秀期刊二等奖,首届国家期刊奖提名奖,中国期刊方阵双奖期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),荷兰文摘与引文数据库,荷兰医学文摘,美国生物医学检索系统,美国生物科学数据库,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:43252